In the United States approved the use of the drug against Ebola for patients with severe COVID-19
Management on sanitary inspection behind quality of foodstuff and medicines may 1, has issued an emergency permit for use of the drug ramdevpir for the treatment of patients with COVID-19, hospitalized with severe. About it it is spoken on a Department site.
Ramdevpir was originally used for the treatment of Ebola.
The resolution was issued after the conduct of clinical trials.
“Although there is limited information on the safety and efficacy of ramdevpir to treat people with COVID-19, clinical trials showed that the study drug decreases the recovery time in some patients”, – stated in the message Department.
Severe disease coronavirus disease means low oxygen levels in the blood of the patient, the need for oxygen therapy or more intensive support of respiration.
Ramdevpir developed by us biopharmaceutical company Gilead Sciences Inc. in 2015. It was used during the Ebola epidemic in Africa, as well as for the treatment of coronavirus infections SARS and MERS.
April 2 ramdevpir introduced Ukrainian treatment Protocol. The Minister of health of Ukraine Maksym Stepanov said that the Ministry of health will purchase the drug for the treatment of ramdevpir COVID-19.
Flash coronavirus infection COVID-19 began in December 2019 in the Chinese city of Wuhan. March 11, 2020, the world health organization declared the spread of the coronavirus pandemic.
As of morning may 2 in Ukraine COVID-19 411 11 sick people, since the beginning of the epidemic 279 died 1498 recovered.
